(Q46466132)

English

Self-assembled peptide-polyoxometalate hybrid nanospheres: two in one enhances targeted inhibition of amyloid β-peptide aggregation associated with Alzheimer's disease

scientific article published on 6 May 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23650245

Self-assembled peptide-polyoxometalate hybrid nanospheres: two in one enhances targeted inhibition of amyloid β-peptide aggregation associated with Alzheimer's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23650245

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

author name string

Meng Li

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23650245

Can Xu

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23650245

Li Wu

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23650245

Jinsong Ren

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23650245

Enbo Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23650245

Xiaogang Qu

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23650245

publication date

6 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23650245

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23650245

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23650245

20

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23650245

3455-3461

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23650245

Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Alzheimer's disease: from pathology to therapeutic approaches

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Cognitive-performance recovery of Alzheimer's disease model mice by modulation of early soluble amyloidal assemblies

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Synthesis of gold nanosheets at a liquid/liquid interface using an amphiphilic polyoxometallate/surfactant hybrid photocatalyst.

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Self-assembly of organic-inorganic hybrid amphiphilic surfactants with large polyoxometalates as polar head groups

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Polyoxometalates as inhibitors of the aggregation of amyloid β peptides associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Surface-modified protein microspheres capture amyloid-β and inhibit its aggregation and toxicity.

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Liberation of copper from amyloid plaques: making a risk factor useful for Alzheimer's disease treatment.

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Bifunctional compounds for controlling metal-mediated aggregation of the aβ42 peptide

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Drug delivery and nanoparticles:applications and hazards

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Using graphene oxide high near-infrared absorbance for photothermal treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Cerebrospinal fluid amyloid beta(1-42) levels in the mild cognitive impairment stage of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Inhibition of amyloid peptide fibrillation by inorganic nanoparticles: functional similarities with proteins

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Polyoxometalates: introduction to a class of inorganic compounds and their biomedical applications

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Cognitive disturbances in old dogs suffering from the canine counterpart of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Polyoxometalates: Building Blocks for Functional Nanoscale Systems

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Spontaneous assembly and real-time growth of micrometre-scale tubular structures from polyoxometalate-based inorganic solids

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201202612

21 January 2018

Identifiers

10.1002/SMLL.201202612

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23650245

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23650245

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46466132&oldid=2112928941"